Beranda › Kanker Kulit › New Jersey
Uji klinis Kanker Kulit di New Jersey
6 studi untuk Kanker Kulit mencari peserta di lokasi di New Jersey.
Kota di New Jersey
Teks studi resmi (Bahasa Inggris)
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- MD Anderson Cancer Center at Cooper, Camden
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT05727904A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT05859074Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
- Hackensack University Medical Center, Hackensack
- Atlantic Health System, Morristown
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Apr 2026 · NCT06947928A Mobile Health Intervention Among Hispanics
- Rutgers Cancer Institute of New Jersey, New Brunswick
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 16 Des 2025 · NCT05389332SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Brunswick
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774Naltrexone and Propranolol Combined With Immunotherapy
- Rutgers Cancer Institute of New Jersey, New Brunswick
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2025 · NCT05968690Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.